Four manufacturers announced roughly $3.25 billion in new US factory investments this week, a cluster of commitments spanning construction equipment, electric-vehicle batteries, biopharmaceuticals and defense munitions. The press releases landed between Monday and Wednesday, each touting advanced automation, job creation and strategic positioning, though the timelines stretch as far as 2031.
Caterpillar bets on compact equipment
Caterpillar will spend about $1 billion on a Sanford, North Carolina plant to build compact track loaders and telehandlers for small contractors and growing businesses. The company described the factory as “modern, technology-enabled” with integrated logistics and digital production systems. No hiring targets, construction schedule or incentive package were disclosed, leaving the capital intensity and local economic impact opaque for now.
Ultium retools for manganese-rich chemistry
Ultium Cells, the General Motors and LG Energy Solution joint venture, plans a $1 billion retool of its Spring Hill, Tennessee facility to produce lithium manganese-rich prismatic cells commercially for the first time. The chemistry promises 33 percent greater energy density than lithium iron phosphate at comparable cost, according to the release. The JV has now committed more than $3.5 billion to the site since its 2019 formation, including a $275 million expansion in 2022. The overhaul begins later this year and targets 2028 completion, adding 500 jobs while the existing high-nickel line continues. The move coincides with the August restart of Ultium’s Ohio plant after a seven-month shutdown attributed to weak consumer demand.
Genentech doubles Oregon fill-finish
Genentech broke ground Monday on a $750 million expansion of its Hillsboro, Oregon campus, adding 211,000 square feet to double the fill-finish footprint. The project carries a 2031 operational start date and 250 roles blending manufacturing with AI, automation and robotics expertise. It sits inside a $50 billion US manufacturing and R&D pledge from parent Roche Group, a figure that dwarfs the near-term outlay and underscores the long horizon of biologics capacity planning.
Avio breaks ground on Virginia rocket motors
Avio USA, the Italian aerospace firm’s subsidiary, began construction Tuesday on a $500 million solid rocket motor plant in Hurt, Virginia. The 900,000-square-foot facility targets thousands of motors annually for Lockheed Martin and Raytheon programs, with about 1,500 jobs expected. Virginia offered up to $97.7 million in performance-based incentives. Production is slated for early 2029, giving the defense supply chain a domestic boost that aligns with Pentagon stockpile priorities.